Bottom line
LHCAX vs FACDX: the short answer
LHCAX (Lord Abbett Health Care Fund) and FACDX (Fidelity Advisor Health Care Fund) are both mutual funds.
But FACDX is far broader, holding 154 positions to 61 for LHCAX, so beyond the top names it adds exposure LHCAX doesn't have.
FACDX is cheaper at 0.96% vs 1.03% — a difference of $7.00 a year per $10,000 invested.
Over five years, LHCAX returned +3.1% a year vs +2.3% for FACDX (reporting dates differ).
LHCAX has a front-end sales load of up to 5.75%; the other does not.
Updated Nov 19, 2026
LHCAX vs FACDX side by side
| LHCAX | FACDX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | Lord Abbett | Fidelity |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 1.03% | 0.96% |
| Annual cost per $10k | $103 | $96 |
| 10-yr cost on $10k (prospectus) | $3,961 | $1,685 |
| Max front load | 5.75% | — |
| 12b-1 fee | 0.25% | 0.25% |
| 1-yr return | +10.9% | +7.7% |
| 5-yr return (annualized) | +3.1% | +2.3% |
| 10-yr return (annualized) | — | +7.6% |
| Best quarter | +21.5% | +21.3% |
| Worst quarter | −11.4% | −15.0% |
| Net assets (fund) | $8.6M | $3.1B |
| Number of holdings | 61 | 154 |
| Portfolio turnover | 91% | 74% |
| Returns as of | Dec 31, 2025 | Sep 30, 2026 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | LHCAX | FACDX | Difference |
|---|---|---|---|
| 2025 | +17.7% | +14.2% | +3.4% |
| 2024 | +7.3% | +3.9% | +3.4% |
| 2023 | +2.9% | +3.8% | −0.9% |
| 2022 | −12.0% | −13.1% | +1.0% |
| 2021 | +8.2% | +11.2% | −2.9% |
| 2020 | +37.1% | +21.1% | +16.1% |
Source: Fund prospectus bar charts
Holdings overlap
11 of LHCAX's top 25 holdings also appear in FACDX's top 25.
| Holding | LHCAX | FACDX |
|---|---|---|
| Eli Lilly & Co | 10.40% | 7.66% |
| UnitedHealth Group Inc | 5.39% | 4.17% |
| Johnson & Johnson | 4.96% | 3.78% |
| Natera Inc | 3.60% | 1.65% |
| Gilead Sciences Inc | 3.53% | 1.25% |
| CVS Health Corp | 3.33% | 1.29% |
| Guardant Health Inc | 2.61% | 1.48% |
| Thermo Fisher Scientific Inc | 2.31% | 6.31% |
| 10X Genomics Inc | 2.16% | 1.45% |
| Ascendis Pharma A/S | 1.99% | 1.95% |
| Revolution Medicines Inc | 1.67% | 1.44% |
Source: SEC Form N-PORT
LHCAX top 10
- Eli Lilly & Co — 10.40%
- UnitedHealth Group Inc — 5.39%
- Johnson & Johnson — 4.96%
- Novartis AG — 4.19%
- Natera Inc — 3.60%
- Gilead Sciences Inc — 3.53%
- CVS Health Corp — 3.33%
- Guardant Health Inc — 2.61%
- Galderma Group AG — 2.60%
- Thermo Fisher Scientific Inc — 2.31%
FACDX top 10
- ELI LILLY and CO — 7.66%
- Danaher Corp — 6.75%
- Thermo Fisher Scientific Inc — 6.31%
- Unitedhealth Group Inc — 4.17%
- JOHNSON and JOHNSON — 3.78%
- Abbvie Inc — 3.62%
- Fidelity Revere Street Trust — 2.54%
- Argenx Se — 2.09%
- MERCK and CO INC — 2.09%
- West Pharmaceutical Svcs Inc — 2.06%
FAQ
What is the difference between LHCAX and FACDX?
Which is cheaper, LHCAX or FACDX?
Should I own both LHCAX and FACDX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.